| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/07/2009 | CN101336682A Honey beverage and preparation method thereof |
| 01/07/2009 | CN100448874C N-aroyl cyclic amines |
| 01/07/2009 | CN100448870C 2-aminoquinoline derivative |
| 01/07/2009 | CN100448868C Tri-substituted heteroaryls and methods of making and using the same |
| 01/07/2009 | CN100448850C Amino 1, 3, 5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof and their use as herbicides and plant growth regulators |
| 01/07/2009 | CN100448446C Buckthorn extract, its preparing method and use in pharmaceutical process |
| 01/07/2009 | CN100448437C Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women |
| 01/06/2009 | US7473771 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
| 01/06/2009 | US7473703 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia |
| 01/06/2009 | US7473698 Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
| 01/06/2009 | US7473425 Remedies for ischemic disease |
| 01/06/2009 | US7473420 Processing adipose tissue to deliver a concentrated amount of stem cells in a closed system so that the stem cells are not exposed to external environment by use of a pre-assembled, linked set of closed, sterile containers and tubing allowing for transfer of tissue and fluid elements within a closed path |
| 01/06/2009 | CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/06/2009 | CA2404335C Vitamin d compounds used to stabilize kidney transplants |
| 01/06/2009 | CA2379086C 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2267244C Methods for treating urinary incontinence in mammals |
| 01/06/2009 | CA2177007C Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/01/2009 | US20090005534 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 01/01/2009 | US20090005438 Use of Isothiocyanates Compounds in Treating Prostatic Diseases and Skin Cancer |
| 01/01/2009 | US20090005412 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/01/2009 | US20090005404 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
| 01/01/2009 | US20090005363 Organic Compounds |
| 01/01/2009 | US20090005355 Piperidine Compound and Process for Preparing the Same |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005318 Controlled release composition and method of producing the same |
| 01/01/2009 | US20090004312 Use of Neurotoxin Therapy for Treatment of Urologic and Related Disorders |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004153 Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using same |
| 12/31/2008 | WO2009002802A2 Liquiritigenin and derivatives as selective estrogen receptor beta agonists |
| 12/31/2008 | WO2009001949A1 Pyrazolone derivative |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY |
| 12/31/2008 | WO2009001043A2 Duloxetine formulation |
| 12/31/2008 | WO2009000558A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | WO2009000085A1 Quinoline and quinazoline derivatives useful as modulators of gated ion channels |
| 12/31/2008 | WO2008136705A3 Drugs for treating and preventing benign prostatic hyperplasia, prostatitis, impotency, infertility and prostate cancer and a method for the use thereof |
| 12/31/2008 | WO2008073388A3 Alfuzosin formulations, methods of making and methods of use |
| 12/31/2008 | EP2008658A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides |
| 12/31/2008 | EP2007348A1 Paediatric amino acid solution for parenteral nutrition |
| 12/31/2008 | EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 12/31/2008 | EP1409483B1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 12/31/2008 | EP1406867B1 Thiolalkyl benzoic acid derivatives |
| 12/31/2008 | EP1312667B1 Probiotic products containing L. salivarius strain |
| 12/31/2008 | EP1268761B1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 12/31/2008 | CN101336230A Pharmaceutical for use in the treatment of ureterolithiasis |
| 12/31/2008 | CN101333256A Human antibodies that bind human il-12 and methods for producing |
| 12/31/2008 | CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/31/2008 | CN101332237A Traditional Chinese medicine composition for treating the prostatitis and preparation method thereof |
| 12/31/2008 | CN101332219A Broken pollen extract and extracting method and use thereof |
| 12/31/2008 | CN101332218A Broken pollen extract and extracting method and use thereof |
| 12/31/2008 | CN101332210A Compound amino acid injection for treating nephrosis |
| 12/31/2008 | CN101332178A Medicinal preparation for oral darifenacin or medicine salt thereof |
| 12/31/2008 | CN101331943A Production method of freeze-dry instant health wood-frog oil |
| 12/31/2008 | CN101331942A Preparation method of nano snow-frog egg powder |
| 12/31/2008 | CN101331933A Health flavouring for nephritis patient |
| 12/31/2008 | CN100447244C BAFF receptor (BCMA), immunoregulatory agent |
| 12/31/2008 | CN100447154C Use of HMG fragments as anti-inflammatory agents |
| 12/31/2008 | CN100446757C Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 12/31/2008 | CA2691371A1 Duloxetine formulation |
| 12/31/2008 | CA2690737A1 6.5-pyrrolopiperidine tachykinin receptor antagonists |
| 12/31/2008 | CA2689299A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/30/2008 | US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response |
| 12/30/2008 | US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 12/30/2008 | US7470687 Aryl oximes |
| 12/30/2008 | CA2432546C Gel for the treatment of cats and dogs |
| 12/30/2008 | CA2351703C Novel 4-dedimethylaminotetracycline derivatives |
| 12/30/2008 | CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 12/30/2008 | CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/30/2008 | CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 12/25/2008 | US20080319051 Liquiritigenin and derivatives as selective estrogen receptor beta agonists |
| 12/25/2008 | US20080319038 Preventative or therapeutic agent for acute renal failure |
| 12/25/2008 | US20080319027 Composition and Method for Treating Fibrotic Diseases |
| 12/25/2008 | US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds |
| 12/25/2008 | US20080319002 Xanthine Derivatives a Useful as Muscarinic Receptor Antagonists |
| 12/25/2008 | US20080318961 Drugs comprising chymase inhibitors and ACE inhibitors as effective ingredients |
| 12/25/2008 | US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 12/25/2008 | US20080318911 20-Cyclopropyl, 26,27-Alkyl/Haloalkyl Vitamin D3 Compounds and Methods of Use Thereof |
| 12/25/2008 | US20080317888 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis |
| 12/25/2008 | US20080317810 Methods and Compositions for Reducing Oxalate Concentrations |
| 12/25/2008 | US20080317728 Lowering Uric Acid to Prevent or Accelerate Recovery of Acute Renal Failure |
| 12/25/2008 | US20080317725 Compositions and methods of treating chronic kidney disease |
| 12/24/2008 | WO2008157205A2 Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp |
| 12/24/2008 | WO2008157060A2 Human umbilical tissue-derived cell compositions for the treatment of incontinence |
| 12/24/2008 | WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 12/24/2008 | WO2008155818A1 Preventive or therapeutic agent for frequent urination and urinary incontinence |
| 12/24/2008 | EP2005952A1 Tamsulosin-containing percutaneous absorption type preparation |
| 12/24/2008 | EP2004232A2 Method and composition for treatment of renal disease with antibodies and their equivalents |
| 12/24/2008 | CN101331134A Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 12/24/2008 | CN101328135A Carbonyl phenyl propanoic acid derivative compounds |
| 12/24/2008 | CN101327283A Composite medicine for treating nephrosis and its preparing process |
| 12/24/2008 | CN101327260A Qingji capsules |
| 12/24/2008 | CN101327246A Radix astragali medicinal materials, intermediate body and method for testing fingerprint of formulation thereof as well as standard fingerprint |
| 12/24/2008 | CN101327225A Bee honey acid composition and preparation method and uses thereof |
| 12/24/2008 | CN101326944A Burdock and coix seed tea prescription and processing technique |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |